GB0711088D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0711088D0
GB0711088D0 GBGB0711088.5A GB0711088A GB0711088D0 GB 0711088 D0 GB0711088 D0 GB 0711088D0 GB 0711088 A GB0711088 A GB 0711088A GB 0711088 D0 GB0711088 D0 GB 0711088D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0711088.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0711088.5A priority Critical patent/GB0711088D0/en
Publication of GB0711088D0 publication Critical patent/GB0711088D0/en
Priority to PCT/EP2008/056971 priority patent/WO2008148836A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
GBGB0711088.5A 2007-06-08 2007-06-08 Compounds Ceased GB0711088D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0711088.5A GB0711088D0 (en) 2007-06-08 2007-06-08 Compounds
PCT/EP2008/056971 WO2008148836A1 (en) 2007-06-08 2008-06-05 Compounds which potentiate ampa receptor and uses thereof in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0711088.5A GB0711088D0 (en) 2007-06-08 2007-06-08 Compounds

Publications (1)

Publication Number Publication Date
GB0711088D0 true GB0711088D0 (en) 2007-07-18

Family

ID=38319020

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0711088.5A Ceased GB0711088D0 (en) 2007-06-08 2007-06-08 Compounds

Country Status (2)

Country Link
GB (1) GB0711088D0 (en)
WO (1) WO2008148836A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011036889A1 (en) * 2009-09-25 2011-03-31 武田薬品工業株式会社 Heterocyclic compound
WO2011036885A1 (en) * 2009-09-25 2011-03-31 武田薬品工業株式会社 Heterocyclic compound
BR112015031249A2 (en) * 2013-06-13 2017-07-25 Veroscience Llc treatment method, method for treating a metabolic disorder or a key element thereof, method for normalizing a daily dopamine release rate in the sumn, method for stimulating dopamine release from dopaminergic neurons in an individual's sumn and pharmaceutical composition
GB201702221D0 (en) 2017-02-10 2017-03-29 Univ Of Sussex Compounds
GB201803340D0 (en) 2018-03-01 2018-04-18 Univ Of Sussex Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781614B1 (en) * 2004-08-09 2009-06-24 Glaxo Group Limited Compounds which potentiate glutamate receptor and uses thereof in medicine
BRPI0710070A2 (en) * 2006-03-20 2011-08-02 Glaxo Group Ltd compounds that potentiate the amp receptor and their uses in medicine
ATE502675T1 (en) * 2006-11-03 2011-04-15 Glaxo Group Ltd COMPOUNDS THAT STRENGTHEN THE AMPA RECEPTOR AND THEIR APPLICATION IN MEDICINE

Also Published As

Publication number Publication date
WO2008148836A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
GB0706793D0 (en) Compounds
GB0704407D0 (en) Compounds
GB0704394D0 (en) Compounds
GB0705672D0 (en) Compounds
GB0706173D0 (en) Compounds
GB0711089D0 (en) Compounds
GB0707092D0 (en) Compounds
GB0706188D0 (en) Compounds
GB0706168D0 (en) Compounds
GB0706165D0 (en) Compounds
GB0707034D0 (en) Compounds
GB0711088D0 (en) Compounds
GB0706189D0 (en) Compounds
GB0706174D0 (en) Compounds
GB0706187D0 (en) Compounds
GB0706167D0 (en) Compounds
GB0706164D0 (en) Compounds
GB0706190D0 (en) Compounds
GB0706170D0 (en) Compounds
GB0704939D0 (en) Compounds
GB0703756D0 (en) Compounds
GB0701985D0 (en) Compounds
GB0706929D0 (en) Compounds
GB0700286D0 (en) Compounds
GB0706160D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)